Partex.AI – The world’s largest AI-powered therapeutic asset accelerator. We’re solving inefficiencies in drug discovery and development using big data and artificial intelligence.
With unmatched computing power, a multidisciplinary team, and rich life sciences data, we help pharma and biotech identify drugs faster, smarter, and for the right patients. Our insights are validated through wet-lab experiments and real-world data—ensuring scalable AI translates into real-world impact.
What we do:
Therapeutics: We revitalize late-stage preclinical and early clinical assets with strong scientific foundations but suboptimal trajectories. Our AI-driven models optimize these toward critical value inflection points. Currently incubating three oncology assets via our SPV structure.
Drug Asset Exchange: Through our Exchange platform, pharma and biotech unlock value in deprioritized or off-strategy assets by leveraging AI-driven in- and out-licensing for efficient portfolio optimization.
Lab & Real-World Data Integration: We’re building a closed-loop model—integrating computational modeling with in-vitro assays and high-throughput screening to validate AI predictions. Our Real-World Data platform supports equitable, scalable healthcare insights via global partnerships.
By unlocking hidden value in therapeutic assets, Partex.AI accelerates the future of data-driven healthcare.
